THBS1 and cancer: Local immunosuppression and resistance to DC immunotherapy is suppressed by intratumoral injection of an anti‐Snail1 siRNA, or by anti‐TSP1 (thrombospondin 1) treatment (Kudo‐Saito et al., 2009), underlining the central role of EMT programs in cancer progression in this model.